The role of membrane transport in the cellular accumulation of
Introduction
l-f3-D-arabinofuranosyl cytosine (ara-C)' is the most effective antimetabolite for the treatment of acute myelogenous leukemia (AML) (1) . The clinical importance of ara-C has stimulated extensive laboratory investigations aimed at understanding biochemical correlates of drug action and mechanisms of drug resistance to provide ideas for better therapeutic strategy. Cytotoxicity has been correlated with the cellular accumulation of ara-C triphosphate (ara-CTP) (2) and its incorporation into DNA (3) (4) (5) . Among the prerequisites for cellular accumulation ofara-diphosphate; Kp, intracellular ara-C concentration for half-maximal phosphorylation; Kt, transport K.; LB-Pt, leukemic blasts isolated directly from patients; NBMPR, nitrobenzylmercaptopurine riboside; Vp, V.
for phosphorylation.
CTP are transport of ara-C across the cell membrane and phosphorylation ofdeoxycytidine kinase. Enhancement ofthe activity of deoxycytidine kinase through biochemical modulation has been a major research focus, and resistance to ara-C has been related to deficient phosphorylation capacity (6) (7) (8) (9) (10) (11) (12) . The role of membrane transport as a determinant of ara-C action in human leukemia has been relatively less explored.
Ara-C has been shown to be a substrate for the facilitated diffusion system for nucleosides (13, 14) . In experimental tumor cells, the rate of ara-C transport is in significant excess of the rate of intracellular phosphorylation (13, 14) . These observations have led to the conclusion that transport will not be an important determinant of ara-C action. However, the studies by Wiley et al. (15) (16) (17) with leukemic blasts isolated directly from patients (LB-Pt) have demonstrated that these cells have substantially lower ara-C transport capacity as compared with established tumor cell lines. In addition, myeloblasts had relatively higher transport capacities and formed more ara-CTP than lymphoblasts (15) (16) (17) . Cells from a small group of AML patients who did not respond to ara-C had low ara-C transport capacity (15) .
The present study was undertaken to examine the role of transport as a determinant of the rate of ara-C phosphorylation in LB-Pt at concentrations achieved in plasma during standard dose and high dose ara-C clinical protocols.
Methods
Materials. Minimum essential medium with Earle's salts and 2 mM glutamine (Flow Laboratories Inc., McLean, VA) was supplemented with 20 mM MOPS (pH 7.4) for use in transport, accumulation, and nitrobenzylmercaptopurine riboside (NBMPR)-binding experiments. FicollPaque (d = 1.077 g/ml) was purchased from Pharmacia Fine Chemicals (Piscataway, NJ). Di-n-butyl phthalate and di-n-octyl phthalate (Aldrich Chemical Co., Milwaukee, WI) were blended 4:1 (vol/vol) to Measurement of ara-C transport. Early in this study, ara-C influx was measured at room temperature using a modification of the method of Wiley et al. (15) . A series of 1.5-ml microfuge tubes containing 100 Ml of [3H]ara-C in media and 150 M1 of phthalate oil were positioned in a microcentrifuge. Influx was started by forcefully injecting 100 Ml ofthe cell suspension (2-3 X IO' cells) and terminated by centrifuging the cells through the oil (8000 g for 30 s). The pellets were solubilized as described for NBMPR binding. Parallel experiments with ['4C]sucrose allowed correction for [3H]ara-C in the extracellular space. The rate of transport was taken as the slope offive to six data points over 30-60 s. Intracellular ara-C remained below 50% of the extracellular level over the interval of observation. The transport Km (KJ) and maximum velocity (V.) of transport (V,) were determined by direct nonlinear fit to the MichaelisMenten equation (21) of influx data at five to six ara-C concentrations.
In Novikoffhepatoma cells, the V, for thymidine transport was increased 3.37-fold, and the Kt was increased 2.03-fold when the temperature was increased from 240 to 370C (22) . To estimate Vt and Kt, for ara-C in LB-Pt we have multiplied Vt and Kt values determined at room temperature by these factors. To estimate the rate at 370C at low concentrations of ara-C (i.e., << Kt), the room temperature rate was multiplied by 3.37/2.03, the ratio of the correction factors for V, and Kt.
For the latter half of this study, influx was measured at 370C by a method based on that of Bowen et al. (23, 24) . To start the flux, 200 Ml of 37°C cell suspension (6-8 X 106 cells) was added to 200 Ml of [3H]ara-C in a 12-ml centrifuge tube which was agitated in a 370C shaker bath.
Influx was terminated by the rapid addition of 10 ml of ice cold PBS containing 20MuM dipyridamole, a potent nucleoside transport inhibitor.
The cell pellets were washed twice with 5 ml dipyridamole-saline, then solubilized and counted as above. Intracellular phosphorylation of [3H]ara-C by deoxycytidine kinase was prevented during influx experiments by 30 -min preincubation of the cells with 50 MM deoxycytidine. Deoxycytidine had no detectable effect on ara-C transport at this concentration in Ehrlich cells (24) . Initial [3H]ara-C uptake data at 370C was curvilinear (see Fig. 1 ), even over short intervals for most populations of LB-Pt. The data was fit by nonlinear regression (21) to equation 1: [IC-ara-C], = [IC-ara-C]infinite 1 -e-k) + [ara-C]o, (1) where [IC-ara-C], is the intracellular ara-C concentration at time t, [ICara-C]jnfinj, is the intracellular ara-C concentration at infinite time (i.e., equal to the extracellular ara-C concentration), and [ara-C] (14) :
where VP is Vm, for phosphorylation. Analysis ofintracellular radiolabel. After a 15-min incubation with [3H]ara-C, 1 ml of the cell suspension was gently layered over 300 Ml of silicone oil which was, in turn, layered over 100 Ml of 10%1 TCA in a 1.5-ml microcentrifuge tube. After centrifugation, the TCA layer was extracted with 150 Ml 0.5 M triocytylamine in freon by a modification of the method of Khym et al. (25) . The volumes of total and extracellular water in the extract were determined from cell suspensions incubated with [3HJ20 or [14C]sucrose, respectively. [3H]ara-C metabolites were quantitated by anion-exchange HPLC (26) . The elution position of radiolabel was compared with standard solutions of ara-C, ara-C monophosphate, ara-C diphosphate (CDP), and ara-CTP. For quantitation of unchanged [3H]ara-C in cell extracts, an aliquot of the cell extract was applied to a 0.6-ml column ofSephadex A25, which binds phosphorylated derivatives of ara-C. The column was eluted with 3 ml ofwater, and the [3H]ara-C applied to similar columns were quantitatively recovered by this procedure.
Computer simulations. Ara-C transport and phosphorylation were simulated by applying the principles of network thermodynamics and the circuit simulation program, SPICE2. The rationale and procedure for describing biochemical pathways as analogous electrical circuits to use circuit simulation software have been previously described (27, 28) .
Calculation of control strength for transport (CJ. Groen et al. (29) developed the concept of Ct to describe the contribution of individual enzymes in a sequential pathway to the overall flux through the pathway.
Wohlhueter and Plagemann (30) 
A complete kinetic analysis of transport is not necessary to estimate
Ct at low ara-C concentrations because transport is essentially first order at concentrations below 100 MM, (i.e. at concentrations < 20% of the 14). The ratio VJKt can be estimated from measurement of transport at a single low ara-C concentration (e.g. I M&M). When [EC-ara-C] << than 1t, equation 4 is equivalent to equation 6.
Kt
Thus, for low extracellular ara-C concentrations [IC-ara-C] can be calculated from this simplified quadratic equation: 
Results
The initial rate of transport of 50 MAM ara-C was much slower in LB-Pt than in established human leukemia cell lines in culture Fig. 1 . Lymphoblasts from patients at initial diagnosis had relatively fewer binding sites per cell than myeloblasts; medians were 1,284 and 3,435 respectively (P < 0.05). Cells from AML patients at initial diagnosis also had fewer sites per cell as compared with cells from patients in relapse, 3,435 vs. 4,420, respectively; however, the difference was not statistically significant. There was no difference between cells isolated from peripheral blood versus those from bone marrow.
At 1 MM ara-C, the initial rate of membrane transport and the rate of net cellular accumulation were similar (Fig. 2) . Inhibition of ara-C transport by 1 MAM NBMPR, a concentration that is -10,000-fold higher than the dissociation constant for (Fig. 3) . The Vp was also elevated in relapse cells (2.22 vs. 1.28 pmol/min per 106 cells, respectively, P = 0.1) (Fig. 3) . The kinetics of transport and accumulation were quite different. Ara-C transport had a much higher V,,t, but also a higher Km (Table II) Because the rates of transport and accumulation of ara-C are similar at low ara-C concentrations, the ara-C can not equilibrate across the plasma membrane, and the intracellular concentration ofunchanged ara-C will be lower than the extracellular level. Heichal et al. (14) have shown that the Kp can be estimated from the kinetic constants for transport and the Vp and [ECara-C]0.5 for phosphorylation (see Methods). The average calculated value for Kp was 2.8 gM. The biochemical basis for this unexpectedly low apparent Km for ara-C phosphorylation in intact LB-Pt is under investigation.
The kinetic constants for transport and phosphorylation have been used to prepare a computer simulation of the time course of initial uptake of 1 or 20 ,M ara-C (Fig. 4) . At 1 ,uM (Fig. 4 A), unchanged ara-C rapidly reached a steady-state intracellular concentration that was less than the extracellular level. Unchanged intracellular ara-C did not approach the extracellular concentration because it was phosphorylated almost as rapidly as it entered the cell. Once this steady-state ara-C concentration was achieved, the rate of metabolism to phosphorylated products became constant. Because the intracellular level was low com- pared with the Kp, the steady-state ara-C concentration was a major determinant of the phosphorylation rate. In Fig. 4 B, the simulation conditions were the same except that Vt was doubled. Because ara-C could now enter the cell twice as fast, the steadystate ara-C concentration increased by 89%, and the net accumulation rate increased by 67%. In Fig. 4 C, the value for Vp was doubled instead. The predicted effect was a decrease in the steady-state ara-C concentration. The increase in metabolic capacity was largely offset by decreased saturation of the phosphorylating enzyme, and the net accumulation rate was increased by only 9%. These simulations suggest that at 1 MM ara-C, the principal determinant ofthe rate ofintracellular phosphorylation is the rate of membrane transport, because alterations in transport capacity have a greater effect than do changes in phosphorylation capacity. Fig. 4 , D-F illustrate simulations at 20 MuM ara-C with AML kinetic constants, doubled Vt, or doubled VP, respectively. At 20 MM ara-C, increasing the transport capacity (Fig. 4 E) caused a small increase in the steady-state ara-C level; however, the steady-state concentration was already high relative to the Kp. Thus, there was almost no effect on the net accumulation velocity. Doubling the Vp at 20 AM ara-C (Fig. 4 F) almost doubled the accumulation rate. In contrast to predictions for 1 MM ara-C (Fig. 4, A-C) , these simulations suggest that the principal determinant of the rate of intracellular phosphorylation at 20 ,M ara-C is the enzymatic phosphorylation capacity.
Measurements of the intracellular concentrations of unmetabolized ara-C in samples from six samples of LB-Pt (Table   III) those with Ehrlich ascites cells, which had similar intracellular and extracellular ara-C concentrations at both high and low ara-C concentrations. These data indicate that transport capacity is in sufficient excess in Ehrlich cells to allow ara-C to equilibrate across the cell membrane.
The concentration dependence of the role of transport as a determinant of intracellular phosphorylation in LB-Pt is best illustrated by calculating the Ct, defined as the role of transport capacity as a determinant on the cellular phosphorylation rate (see Methods). A Ct of 1.0 would mean that the phosphorylation rate was a direct function ofthe transport rate while a Ct ofzero would mean that the phosphorylation rate was independent of the transport rate. The solid line in Fig. 5 is based on median values for VdKt, Vp, and Kp in AML cells from Table II. At 1 MM ara-C, Ct was 0.85, indicating that a 1% increase in Vt would cause a 0.85% increase in the cellular phosphorylation rate. The accumulation rate would increase by only 0.15% if the Vp were increased by 1% at this low ara-C concentration. As the extracellular ara-C concentration is increased, the Ct falls because the transport capacity increases relative to the phosphorylation capacity. The LB-Pt samples have been heterogeneous with respect to their kinetic parameters for transport and phosphorylation, and therefore with respect to their dependence on the rate of transport as a determinant ofthe rate ofintracellular metabolism. The dashed line in Fig. 5 shows the dependence of C, on ara-C concentration for cells from an AML patient in which transport only partially determines the rate of intracellular phosphorylation. Ct was only 0.41, even at low ara-C concentrations. By contrast, transport is the primary determinant ofthe rate ofara-C metabolism (i.e., Ct > 0.5) at concentrations up to 7 AM in cells from another AML patient (dashed line).
Discussion
Ara-C is a substrate for the carrier that facilitates the nonconcentrative transport of a wide variety of nucleosides and nucleoside analogs across the cell membrane (13) . Experimental tumor cells treated with inhibitors of the nucleoside carrier (35, Table II ). (Fig.  1) . Cells from ALL patients returning in relapse, however, had higher NBMPR-binding capacities than similar cells from AML patients. These data must be interpreted with caution due to the small number of ALL samples in our study to date.
When cells are exposed to [3H]ara-C, the concentration of total intracellular radiolabel rapidly exceeds the concentration of extracellular ara-C. Ara-C is phosphorylated to ara-CMP by deoxycytidine kinase and then rapidly converted to ara-CDP and ara-CTP. These phosphory!ated derivatives are not able to cross the cell membrane and therefore, they accumulate within the cell. The early rate of accumulation of radiolabel (i.e., from 2 to 30 min) is thus a measure of the rate of intracellular phosphorylation of ara-C. An alternate route for accumulation of radiolabel, deamination ofara-C to ara-U, and phosphorylation ofara-U to ara-UMP, has been specifically ruled out in the studies described above.
Of interest was the increase in both the transport rate (at 1 AM ara-C) and the Vp The rate of cellular phosphorylation of ara-C is determined by the properties and activity of the kinase and also by the concentration ofintracellular ara-C. At intracellular concentrations of the nucleoside that are low relative to the Kp, the phosphorylation rate is proportional to the substrate concentration (i.e., first order). Low transport capacity may limit the phosphorylation rate by limiting the availability of intracellular substrate. Computer simulations indicated that at low extracellular concentrations (< 1 AM), ara-C is phosphorylated almost as rapidly as it enters the cell, and the intracellular nucleoside concentration is much lower than the extracellular level. This prediction was confirmed by direct measurement of unchanged ara-C (Table  III) . The simulations also indicated that an increase in the transport capacity would have a greater effect on the cellular phosphorylation rate than an increase in deoxycytidine kinase activity. At low extracellular ara-C concentrations, an increase in transport capacity results in an increase in the concentration of intracellular ara-C (nucleoside), which results in an increase in the cellular phosphorylation rate. An increase in deoxycytidine kinase activity would not increase the cellular phosphorylation rate as much because the concentration of its substrate, intracellular ara-C would decline. Calculation ofthe Ct illustrates this Transport Transport velocity is nearly proportional to concentration up to at least 100 MM. As described above, the rate ofintracellular phosphorylation reached a maximum at relatively low concentrations. Thus, the rate of transport increases relative to the rate of phosphorylation as the extracellular ara-C concentration is increased. At high extracellular ara-C levels, the steady state intracellular ara-C concentration approaches the extracellular level, and variations in transport capacity have only minor effects on the intracellular ara-C level. Moreover, at intracellular concentrations above the Km for phosphorylation, the phosphorylation rate is less dependent on the intracellular nucleoside concentration (i.e., the phosphorylation rate becomes zero order with respect to substrate), and an increase in the intracellular ara-C concentration toward the extracellular concentration has a smaller effect on the phosphorylation velocity. Thus, transport becomes less important as a determinant of the rate of cellular phosphorylation at high substrate levels. The C, in the average LB-Pt falls to 0.5 at 5 A.M and is only 0.1 at 10 MM. We have shown in a previous paper (24) that inhibition of ara-C transport by the epipodophyllotoxin, VM-26, slowed the rate of accumulation of 1 MM ara-C in LB-Pt, but there was no effect on the accumulation rate at 50MM ara-C, because ara-C transport was rate limiting at the lower but not the higher concentration.
For cells from most AML patients, ara-C transport will be the principal rate-determining step for net uptake (i.e., Ct will be high) during low or standard dose ara-C treatment regimens (e.g., 100-200 mg/M2) that generate plasma levels below 1 ,M (41, 42). Transport will be in excess (i.e., Ct will be low) and will not be a determinant of the rate of drug accumulation in high dose regimens (e.g., 3 g/m2) that generate plasma levels above 50MM (43, 44) . Thus, high dose ara-C protocols, which generate high plasma ara-C concentrations, minimize or eliminate a potential pharmacologic obstacle and allow anabolism of ara-C to proceed at maximum rates. This difference in the relative importance oftransport may contribute to the distinction in efficacy of high dose vs. standard dose ara-C treatment protocols (40) .
